Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 7, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
- Aug 7, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Jul 8, 2026Notice of sale · Form 144Wilson John J. Addington · Former Officer · $17.0KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record2925 flagged findings
Reported transactions (Form 4)80since May 23, 2024
Corporate events (8-K)18since Sep 23, 2021
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
The 25 most recent filings (of 292)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Bain Capital Life Sciences Fund, L.P. · 16.8% · event on Jun 30, 26 · amendment
- Aug 14, 26SCHEDULE 13G ↗Passive stake · Armistice Capital, LLC · 7.3% · event on Jun 30, 26
- Aug 7, 2610-Q ↗Quarterly report
- Aug 7, 268-K ↗Current report · Results
Notice of proposed sale · 4 Form 144 filingsshow all 4hide
- Jul 8, 26Form 144 ↗Notice of proposed sale
- Jul 1, 26Form 144 ↗Notice of proposed sale
- Jun 22, 26Form 144 ↗Notice of proposed sale
- Jun 10, 26Form 144 ↗Notice of proposed sale
- May 28, 268-K ↗Current report · Shareholder vote results
- May 19, 268-K ↗Current report · Entered a material agreement
- May 19, 26424B5 ↗Securities offering
- May 19, 26424B5 ↗Securities offering
292 filings on record, the oldest from Apr 19, 21.
Listing the 25 most recent filings of the 292 on record.
477
- May 19, 26Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Mar 27, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Aug 12, 25Entered a material agreement+5 more in the same filing8-K 1.01 ↗
- May 23, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Feb 27, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Nov 1, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
3 listing notices2023 – 2024show all 3hide
- Aug 2, 24Listing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
- Feb 2, 24Listing notice (8-K 3.01)8-K 3.01 ↗
- Sep 19, 23Listing notice (8-K 3.01)8-K 3.01 ↗
- Jul 18, 23A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Aug 12, 22Restructuring plan with committed costs+7 more in the same filing8-K 2.05 ↗
- Mar 29, 22A senior executive left or was appointed8-K 5.02 ↗
- Dec 23, 21A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Sep 23, 21A material agreement was terminated+1 more in the same filing8-K 1.02 ↗
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- SPIGNESI ROBERT G JR6.3%Mar 28, 24SCHEDULE 13D ↗
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Bain Capital Life Sciences Fund, L.P.16.8%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- Longitude Capital Partners II, LLC8.6%Mar 31, 26SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum.
- Armistice Capital, LLC7.3%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- Endeavour Medtech Growth II LP5.7%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Jul 8, Wilson John J. Addington filed notice of intent to sell up to $17K. That is about 0.02% of shares outstanding.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
The 90-day window closed with no sale of theirs on record in Form 4.
View notice (Form 144) ↗+2 more recent notices
- Mar 11, 26Sell$32KSEAN M WIRTJESCHIEF FINANCIAL OFFICER↗
- Mar 11, 26Sell$41KJohn J. Addington WilsonCHIEF OPERATING OFFICER↗
- Mar 10, 26Sell$74KRobert G. Spignesi Jr.PRESIDENT AND CEO↗
- Feb 20, 26Sell$68KSEAN M WIRTJESCHIEF FINANCIAL OFFICER↗
- Feb 20, 26Sell$21KJohn J. Addington WilsonCHIEF OPERATING OFFICER↗
- Feb 19, 26Sell$149KRobert G. Spignesi Jr.PRESIDENT AND CEO↗
- Feb 9, 26Sell$23KSEAN M WIRTJESCHIEF FINANCIAL OFFICER↗
- Feb 9, 26Sell$49KRobert G. Spignesi Jr.PRESIDENT AND CEO↗
- Feb 9, 26Sell$17KJohn J. Addington WilsonCHIEF OPERATING OFFICER↗
- Feb 4, 26Sell$190KLongitude Capital Partners II, LLC↗
- Feb 3, 26Sell$117KLongitude Capital Partners II, LLC↗
- Feb 2, 26Sell$117KLongitude Capital Partners II, LLC↗
There are 3 more transactions in this stretch.
Stock compensation, tax and giftsshow the 25 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Jul 24, 26Compensation$1KRichard S Kollender↗
- Jul 24, 26Compensation$1KRichard S Kollender↗
- Jul 22, 26Compensation$1KRobert G. Spignesi Jr.PRESIDENT AND CEO↗
- May 29, 26Compensation$25KSEAN M WIRTJESCHIEF FINANCIAL OFFICER↗
- May 29, 26Compensation$25KKirk Malloy↗
- May 29, 26Compensation$25KMELINDA LITHERLAND PEI↗
- May 29, 26Compensation$25KRobert G. Spignesi Jr.PRESIDENT AND CEO↗
- May 29, 26Compensation$25KINESE LOWENSTEIN↗
- May 21, 26Compensationamount n/aKirk Malloy↗
- May 21, 26Compensationamount n/aRichard S Kollender↗
- May 21, 26Compensationamount n/aMELINDA LITHERLAND PEI↗
- May 21, 26Compensationamount n/aINESE LOWENSTEIN↗
- May 21, 26Compensationamount n/aDafni Bika↗
- Feb 27, 26Compensation$632NATALE S RICCIARDI↗
- Feb 11, 26Compensationamount n/aRobert G. Spignesi Jr.PRESIDENT AND CEO↗
- Feb 11, 26Compensationamount n/aSEAN M WIRTJESCHIEF FINANCIAL OFFICER↗
- Feb 11, 26Compensationamount n/aJohn J. Addington WilsonCHIEF OPERATING OFFICER↗
- Jan 23, 26Other$31KLongitude Capital Partners II, LLC↗
- Nov 14, 25Giftamount n/aKirk Malloy↗
- Oct 17, 25Compensation$3KRobert G. Spignesi Jr.PRESIDENT AND CEO↗
- Oct 17, 25Tax$6KRobert G. Spignesi Jr.PRESIDENT AND CEO↗
- Oct 17, 25Compensation$6KRobert G. Spignesi Jr.PRESIDENT AND CEO↗
- Oct 17, 25Tax$15KRobert G. Spignesi Jr.PRESIDENT AND CEO↗
- Jul 14, 25Compensationamount n/aRobert G. Spignesi Jr.PRESIDENT AND CEO↗
- Jul 11, 25Compensationamount n/aRobert G. Spignesi Jr.PRESIDENT AND CEO↗
The full record holds 113 transactions and goes back to Feb 13, 23.
Its sector and its market
Rapid Micro Biosystems, Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
- Quince Therapeutics, Inc. QNCX
- RadNet Inc. RDNT
- Rallybio Corporation RLYB
- Ramsay Générale de Santé SA GDS
- Rani Therapeutics Holdings Inc. RANI
- Rapport Therapeutics Inc. RAPP
- Recordati Industria Chimica e Farmaceutica S.p.A. 0KBS
- Recursion Pharmaceuticals, Inc. RXRX
- Redcare Pharmacy N.V. RDC
- Regencell Bioscience Holdings Ltd. RGC
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Rapid Micro Biosystems, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Rapid Micro Biosystems, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 292 documents on file, from Apr 19, 2021 to Aug 14, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.